Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Healthy Subjects
Clinical trial NCT06043739 · COMPLETED
Trial details
- NCT number
- NCT06043739
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-22
- Primary completion
- 2023-10-27
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.